Fed up with Ads? Install Dainik Bhaskar app for news without ads
London25 minutes ago
- Copy link
Oxford University and Astragenica Company in the UK have started vaccine trials on children aged 6 to 17 years. The first dose of vaccine has been given to 240 children. (File)
Oxford University and Astragenica have begun preparations to produce a special Kovid-19 vaccine for children. Trials have also started in London. A total of 300 children are participating in it. Their age is between 6 to 17 years. One of the motives of this trial is to know how effective the current vaccine is for children in this age group. Currently, people who are being vaccinated in Britain are 18 years of age or older.
Trial at multiple centers
According to a report by itv.com, this Oxford-Astragenica vaccine trial began on Saturday. For this, the company has started processing at many centers. Initially, 240 children have been given vaccine doses. Myra, 16, wrote on social media – I too am participating in the trial as a volunteer. Hopefully we will get better results. During the entire pandemic, I was waiting for how I could contribute.
Second dose four weeks later
A total of three vaccines have been approved in the UK. These include Pfizer-BioNotech and Moderna in addition to Oxford-Astragenica. Some children have been given the first dose. The second dose will be given after four weeks. “We want to see that the vaccine has the same effect on children of this age as adults,” said nurse Hannah Robinson, who is on the clinical trial team. It is important to know its FICC. If this happens, children will also be protected from the epidemic and by the end of the year, vaccines may be present for them as well.